Cetera Investment Advisers
DERM icon

Cetera Investment Advisers’s Journey Medical DERM Stock Holding History

Cetera Investment Advisers’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48K Buy
+10,225
New +$79.4K ﹤0.01% 4586
2025
Q3 		– Sell
-10,731
Closed -$77K – 4591
2025
Q2 		$77K Sell
10,731
-4,418
-29% -$30.5K ﹤0.01% 3922
2025
Q1 		$89.4K Buy
15,149
+1,310
+9% +$6.44K ﹤0.01% 3795
2024
Q4 		$54.1K Buy
13,839
+2,478
+22% +$13.5K ﹤0.01% 3651
2024
Q3 		$64.2K Sell
11,361
-7,252
-39% -$37.3K ﹤0.01% 3583
2024
Q2 		$105K Buy
+18,613
New +$76.6K ﹤0.01% 3508

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Cetera Investment Advisers's DERM Position: Q1 2026 in Review

Cetera Investment Advisers opened a new position in Journey Medical (DERM) in Q1 2026: 10,225 shares worth $48K. The stake represents ﹤0.01% of the portfolio and ranks #4586 among its holdings. This is a return to the name: Cetera Investment Advisers previously reported a position in DERM as recently as Q2 2025.

Cetera Investment Advisers first reported a position in DERM in Q2 2024 and has held it in 6 quarters since. The position peaked at $105K in Q2 2024. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • Cetera Investment Advisers held 10,225 shares of Journey Medical worth $48K as of Q1 2026.
  • Journey Medical was a new Cetera Investment Advisers position in Q1 2026.
  • Journey Medical made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #4586 holding.
  • Cetera Investment Advisers first reported a position in Journey Medical in Q2 2024 and has held it in 6 quarters since.
  • Cetera Investment Advisers's Journey Medical position peaked at $105K in Q2 2024.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.